Using Twitter Data to Understand Public Perceptions of Approved versus Off-label Use for COVID-19-related Medications
Understanding public discourse on emergency use of unproven therapeutics is
essential to monitor safe use and combat misinformation. We developed a natural
language processing (NLP)-based pipeline to understand public perceptions of
and stances on COVID-19-related drugs on Twitter across time. This
retrospective study included 609,189 US-based tweets between January 29th, 2020
and November 30th, 2021 on four drugs that gained wide public attention during
the COVID-19 pandemic: 1) Hydroxychloroquine and Ivermectin, drug therapies
with anecdotal evidence; and 2) Molnupiravir and Remdesivir, FDA-approved
treatment options for eligible patients. Time-trend analysis was used to
understand the popularity and related events. Content and demographic analyses
were conducted to explore potential rationales of people's stances on each
drug. Time-trend analysis revealed that Hydroxychloroquine and Ivermectin
received much more discussion than Molnupiravir and Remdesivir, particularly
during COVID-19 surges. Hydroxychloroquine and Ivermectin were highly
politicized, related to conspiracy theories, hearsay, celebrity effects, etc.
The distribution of stance between the two major US political parties was
significantly different (p<0.001); Republicans were much more likely to support
Hydroxychloroquine (+55%) and Ivermectin (+30%) than Democrats. People with
healthcare backgrounds tended to oppose Hydroxychloroquine (+7%) more than the
general population; in contrast, the general population was more likely to
support Ivermectin (+14%). We make all the data, code, and models available at
https://github.com/ningkko/COVID-drug.